‘A tragedy of the commons’: How a VC wants to lower drug prices - STAT

‘A tragedy of the commons’: How a VC wants to lower drug prices - STAT

STAT Plus: ‘We have a tragedy of the commons’: How a VC thinks his new company can lower drug prices

By ADAM FEUERSTEIN AND MATTHEW HERPER

JESSICA RINALDI/THE BOSTON GLOBE

Alexis Borisy seeks to bring down drug prices by making equivalars, blockbuster look-alikes that have their own intellectual property but cost far less.

READ MORE